Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Preliminary Exploratory Clinical Study of TC-D101 in the Treatment of DLL3-Positive Relapsed/Refractory Primary Small Cell Lung Cancer

NCT07246304 is registered in ClinicalTrials.gov with TCRCure Biopharma Ltd. as lead sponsor.

NCT NCT07246304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07246304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Preliminary Exploratory Clinical Study of TC-D101 in the Treatment of DLL3-Positive Relapsed/Refractory Primary Small Cell Lung Cancer
Lead sponsor
TCRCure Biopharma Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
November 30, 2025
Completion date
November 30, 2028
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

car-t cell therapy, small cell lung cancer ( sclc )